Brief: Medicare Issues Local Coverage Determination For Biocept’S Target Selector™ Breast Cancer Assay To Detect The Her2 Biomarker From Circulating Tumor Cells
21/07/2021 13:23
July 21 (Reuters) - Biocept Inc BIOC.O :
* MEDICARE ISSUES LOCAL COVERAGE DETERMINATION FOR BIOCEPT’S
TARGET SELECTOR™ BREAST CANCER ASSAY TO DETECT THE HER2
BIOMARKER FROM CIRCULATING TUMOR CELLS
Source text for Eikon: ID:nBw3Gm3Hra
Further company coverage: BIOC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biocept
See all newsBrief: Biocept Says Trading Of Common Stock Will Be Suspended By Nasdaq At Opening Of Business On Oct 25
U.S. STOCKS ON THE MOVE-Overstock.com, Biocept, Birkenstock
Biocept slumps after filing for bankruptcy protection
Brief: Biocept CEO Antonino Morales Resigns
U.S. STOCKS ON THE MOVE-Albemarle, Novavax, WeWork